Pre-clinical models of infectious diseases
Ended Awarded Last action
- Contract number
- 75N93024F00002
- Awardee
-
Saint Louis University UEI JNBLLTBTLLD8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,773
Award facts
- Contract value 21% obligated
-
- $400,773.00 Current, with exercised options
- $1,871,862.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- St. Louis, MO 63103, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $400,773 |
About this award
Saint Louis University (SLU) was awarded a delivery order valued at $1.87M by the National Institute of Allergy and Infectious Diseases (NIAID) on September 13, 2024, for the development and provision of hamster models for human adenovirus research. The contract, which carries a cost-no-fee pricing structure with no set-aside designation, supports pre-clinical infectious disease modeling and is expected to be completed by May 12, 2026. Work will be performed at SLU's facility in St. Louis, Missouri. This delivery order falls under NIAID's larger $146.3M indefinite delivery vehicle with SLU that funds comprehensive pre-clinical models of infectious diseases, including small animal models, non-human primate models, and specialized reagents supporting the agency's infectious disease research and pandemic preparedness initiatives.
The hamster model delivery order advances NIAID's capacity to screen, evaluate, and develop candidate countermeasures against infectious agents, including those with pandemic potential and antimicrobial-resistant infections. SLU, a private nonprofit Jesuit research university with an established track record in translational research and federal partnerships, brings significant expertise in specialized animal model development and infectious disease research. The contract represents continued investment in critical research infrastructure that supports national infectious disease preparedness and accelerates the development of medical countermeasures across multiple threat categories.
Quick answers
Who was awarded contract 75N93024F00002?
75N93024F00002 was awarded to Saint Louis University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 13, 2024.
How much is contract 75N93024F00002 worth?
The government has obligated $400,773 on 75N93024F00002. Its potential value, with all options, is $1,871,862.
Is contract 75N93024F00002 an order under another contract?
Yes. 75N93024F00002 is a delivery order under 75N93024D00019, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024F00002 competed?
The extent of competition for 75N93024F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award